Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
APPH | F
Overview
Corporate Details
- ISIN(s):
- DE000A3CMGM5 (+1 more)
- LEI:
- 894500ETO1J6MR8PDF91
- Country:
- Germany
- Address:
- Alfred-Nobel-Straße 10, 40789 Monheim am Rhein
- Website:
- https://apontis-pharma.de/en/
- Sector:
- Manufacturing
Description
Apontis Pharma AG is a pharmaceutical company that specializes in the development, marketing, and distribution of 'Single Pills'. These are fixed-dose combination drugs that unite two or three active pharmaceutical ingredients into a single tablet. The company's portfolio primarily focuses on treating cardiovascular diseases and other chronic conditions. By simplifying treatment regimens, the Single Pill approach aims to improve patient adherence and therapy outcomes, offering medical and economic benefits to the healthcare system. Apontis Pharma also engages in co-marketing activities for established pharmaceutical products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-10 21:23 |
APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Gree…
|
English | 17.1 KB | ||
| 2021-06-10 21:20 |
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
|
English | 65.5 KB | ||
| 2021-05-28 20:05 |
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
|
English | 16.8 KB | ||
| 2021-05-20 07:30 |
APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Sin…
|
English | 9.0 KB | ||
| 2021-05-19 20:23 |
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
|
English | 82.8 KB | ||
| 2021-05-06 20:09 |
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
|
English | 13.8 KB | ||
| 2021-05-06 20:07 |
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
|
English | 10.0 KB | ||
| 2021-04-29 08:30 |
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24…
|
English | 18.3 KB | ||
| 2021-04-21 08:30 |
APONTIS PHARMA plans initial public offering
|
English | 26.7 KB |
Automate Your Workflow. Get a real-time feed of all Apontis Pharma AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Apontis Pharma AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Apontis Pharma AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-14 | Milz, Thomas | Board | Buy | None | 8,960.00 EUR |
| 2024-05-14 | be executive GmbH | Close relation | Buy | None | 8,880.00 EUR |
| 2024-05-13 | Zimmermann, Thomas | Other | Buy | None | 10,128.00 EUR |
| 2024-05-13 | Zimmermann, Thomas | Other | Buy | None | 3,396.00 EUR |
| 2024-05-13 | Zimmermann, Thomas | Other | Buy | None | 1,692.00 EUR |
| 2024-05-13 | Zimmermann, Thomas | Other | Buy | None | 1,688.00 EUR |
| 2023-05-05 | Reineke, Silke | Close relation | Buy | None | 36,625.00 EUR |
| 2023-05-05 | Milz, Thomas | Board | Buy | None | 14,360.00 EUR |
Peer Companies
